cancer

New Research for Borderline Resectable Locally Advanced Pancreatic Cancer Patients

PLYMOUTH MEETING, PA — New research in the September 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic …

New Research for Borderline Resectable Locally Advanced Pancreatic Cancer Patients Read More

medical news

Panavance Therapeutics Announces Publication of Encouraging Preclinical Data Evaluating GP-2250

BERWYN, PA — Panavance Therapeutics Inc. announced the recent publication of positive data from a preclinical study evaluating GP-2250 for the treatment of pancreatic neuroendocrine carcinoma. The manuscript titled, “New …

Panavance Therapeutics Announces Publication of Encouraging Preclinical Data Evaluating GP-2250 Read More